Possible kidney-lung cross-talk in COVID-19: in silico modeling of SARS-CoV-2 infection.
ACE2
Acute kidney injury
COVID receptors
Gene expression
Genomics
Kidney-lung cross-talk
Microarray
TMPRSS2
Journal
BMC nephrology
ISSN: 1471-2369
Titre abrégé: BMC Nephrol
Pays: England
ID NLM: 100967793
Informations de publication
Date de publication:
05 02 2022
05 02 2022
Historique:
received:
27
05
2021
accepted:
22
01
2022
entrez:
6
2
2022
pubmed:
7
2
2022
medline:
25
2
2022
Statut:
epublish
Résumé
Publicly available genomics datasets have grown drastically during the past decades. Although most of these datasets were initially generated to answer a pre-defined scientific question, their repurposing can be useful when new challenges such as COVID-19 arise. While the establishment and use of experimental models of COVID-19 are in progress, the potential hypotheses for mechanisms of onset and progression of COVID-19 can be generated by using in silico analysis of known molecular changes during COVID-19 and targets for SARS-CoV-2 invasion. Selecting condition: COVID-19 infection leads to pneumonia and mechanical ventilation (PMV) and associated with acute kidney injury (AKI). There is increasing data demonstrating mechanistic links between AKI and lung injury caused by mechanical ventilation. Selecting targets: SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) for cell entry. We hypothesized that expression of ACE2 and TMPRSS2 would be affected in models of AKI and PMV. We therefore evaluated expression of ACE2 and TMPRSS2 as well as other novel molecular players of AKI and AKI-lung cross-talk in the publicly available microarray datasets GSE6730 and GSE60088, which represent gene expression of lungs and kidneys in mouse models of AKI and PMV, respectively. Expression of COVID-19 related genes ACE2 and TMPRSS2 was downregulated in lungs after 6 h of distant AKI effects. The expression of ACE2 decreased further after 36 h, while expression of TMPRSS2 recovered. In kidneys, both genes were downregulated by AKI, but not by distant lung injury. We also identified 53 kidney genes upregulated by PMV; and 254 lung genes upregulated by AKI, 9 genes of which were common to both organs. 3 of 9 genes were previously linked to kidney-lung cross-talk: Lcn2 (Fold Change (FC) Using our in silico approach, we identified changes in COVID-19 related genes ACE2 and TMPRSS2 in traditional mouse models of AKI and kidney-lung cross-talk. We also found changes in new candidate genes, which could be involved in the combined kidney-lung injury during COVID-19.
Sections du résumé
BACKGROUND
Publicly available genomics datasets have grown drastically during the past decades. Although most of these datasets were initially generated to answer a pre-defined scientific question, their repurposing can be useful when new challenges such as COVID-19 arise. While the establishment and use of experimental models of COVID-19 are in progress, the potential hypotheses for mechanisms of onset and progression of COVID-19 can be generated by using in silico analysis of known molecular changes during COVID-19 and targets for SARS-CoV-2 invasion.
METHODS
Selecting condition: COVID-19 infection leads to pneumonia and mechanical ventilation (PMV) and associated with acute kidney injury (AKI). There is increasing data demonstrating mechanistic links between AKI and lung injury caused by mechanical ventilation. Selecting targets: SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) for cell entry. We hypothesized that expression of ACE2 and TMPRSS2 would be affected in models of AKI and PMV. We therefore evaluated expression of ACE2 and TMPRSS2 as well as other novel molecular players of AKI and AKI-lung cross-talk in the publicly available microarray datasets GSE6730 and GSE60088, which represent gene expression of lungs and kidneys in mouse models of AKI and PMV, respectively.
RESULTS
Expression of COVID-19 related genes ACE2 and TMPRSS2 was downregulated in lungs after 6 h of distant AKI effects. The expression of ACE2 decreased further after 36 h, while expression of TMPRSS2 recovered. In kidneys, both genes were downregulated by AKI, but not by distant lung injury. We also identified 53 kidney genes upregulated by PMV; and 254 lung genes upregulated by AKI, 9 genes of which were common to both organs. 3 of 9 genes were previously linked to kidney-lung cross-talk: Lcn2 (Fold Change (FC)
CONCLUSIONS
Using our in silico approach, we identified changes in COVID-19 related genes ACE2 and TMPRSS2 in traditional mouse models of AKI and kidney-lung cross-talk. We also found changes in new candidate genes, which could be involved in the combined kidney-lung injury during COVID-19.
Identifiants
pubmed: 35123426
doi: 10.1186/s12882-022-02682-1
pii: 10.1186/s12882-022-02682-1
pmc: PMC8817768
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
57Informations de copyright
© 2022. The Author(s).
Références
Mayo Clin Proc. 2021 Nov;96(11):2748-2752
pubmed: 34736607
Clin Infect Dis. 2021 Mar 1;72(5):905-906
pubmed: 32544219
Biochem Biophys Res Commun. 1999 Oct 14;264(1):86-92
pubmed: 10527846
J Am Soc Nephrol. 2020 Aug;31(8):1917-1918
pubmed: 32639940
J Immunol. 2017 May 15;198(10):4046-4053
pubmed: 28373583
J Am Soc Nephrol. 2020 Jul;31(7):1380-1383
pubmed: 32366514
Clin Sci (Lond). 2020 Jul 31;134(14):1887-1909
pubmed: 32662516
Am J Physiol Renal Physiol. 2019 Feb 1;316(2):F241-F252
pubmed: 30379099
Shock. 2016 Feb;45(2):148-56
pubmed: 26536201
J Am Soc Nephrol. 2006 Nov;17(11):3124-31
pubmed: 17035612
Mol Med Rep. 2018 Jul;18(1):31-40
pubmed: 29749505
J Am Soc Nephrol. 2003 Jun;14(6):1549-58
pubmed: 12761255
Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12543-7
pubmed: 16116101
Am J Kidney Dis. 2000 May;35(5):871-7
pubmed: 10793021
J Pathol. 2001 Jan;193(1):134-40
pubmed: 11169526
Crit Care. 2020 Jul 13;24(1):422
pubmed: 32660650
Front Public Health. 2020 Apr 29;8:152
pubmed: 32411652
Am J Physiol Renal Physiol. 2007 Jul;293(1):F30-40
pubmed: 17327501
J Am Soc Nephrol. 2008 Mar;19(3):547-58
pubmed: 18235097
Nephrology (Carlton). 2021 Mar;26(3):239-247
pubmed: 33150674
J Am Soc Nephrol. 2007 Jan;18(1):155-64
pubmed: 17167117
Kidney Int. 2020 Dec;98(6):1370-1372
pubmed: 32920023
Kidney Int. 2014 Jun;85(6):1357-68
pubmed: 24402091